A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma
Clinical trial NCT03345095 · COMPLETED
Trial details
- NCT number
- NCT03345095
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-26
- Primary completion
- 2022-08-23
- Enrollment
- 749
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.